Response to the Letter of R. Merget, I. Feder and A. Tannapfel

• References

• 1 Baur X. Asbestos: Socio-legal and Scientific Controversies and Unsound Science in the Context of the Worldwide Asbestos Tragedy – Lessons to be Learned. Pneumologie 2016; 70: 405-412
• 2 Baur X. Clasen M. Fisseler-Eckhoff A. et al. [Diagnostics and expert opinion of asbestos-induced occupational diseases]. Pneumologie 2011; 65: e1-47
• 3 Baur X. Frank AL. Budnik LT. et al. Collegium Ramazzini: Comments on the 2014 Helsinki consensus report on asbestos. Am J Ind Med 2016; 59: 591-594
• 4 Begin R. Christman JW. Detailed occupational history: the cornerstone in diagnosis of asbestos-related lung disease. Am J Respir Crit Care Med 2001; 163: 598-599
• 5 Hammar SP. Abraham JL. Commentary on pathologic diagnosis of asbestosis and critique of the 2010 Asbestosis Committee of the College of American Pathologists (CAP) and Pulmonary Pathology Society's (PPS) update on the diagnostic criteria for pathologic asbestosis. Am J Ind Med 2015; 58: 1034-1039
• 6 Roggli VL. Gibbs AR. Attanoos R. et al. Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of american pathologists and pulmonary pathology society. Arch Pathol Lab Med 2010; 134: 462-480
• 7 Craighead JE. Abraham JL. Churg A. et al. The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. Arch Pathol Lab Med 1982; 106: 544-596
• 8 Baur X. Asbest: Der Kampf um einen effektiven Arbeitsschutz, das Asbestverwendungsverbot und eine gerechte Kompensation der Asbestopfer. Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie 2015; 65: 340-346
• 9 Mertens G. Brandenburg S. Die Berufskrankheitenverordnung (BKV). Handkommentar aus rechtlicher und medizinischer Sicht für Ärzte, Versicherungsträger und Sozialgerichte. Berlin: Erich Schmidt Verlag; 2009
• 10 Woitowitz H-J. Die Asbestkörperchen-Theorie ist tot. Deutsches Mesotheliomregister – was nun?. Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie 2016; 66: 232-238
• 11 Mesotheliomregister D. Deutsches Mesotheliomregister Jahresbericht. 2014 Im Internet: http://www.ruhr-uni-bochum.de/pathologie/mam/content/jahresbericht2014.pdf
• 12 BMAS. Sicherheit und Gesundheit bei der Arbeit. 2014 http://www.baua.de/de/Informationen-fuer-die-Praxis/Statistiken/Berufskrankheiten/Berufskrankheiten.html
• 13 Takala Y. Eliminating occupational cancer in Europe and globally. Im Internet: https://www.etui.org/content/download/21462/179550/file/WP%2B2015-10-Eliminating%2Boccupational%2Bcancer%2BWeb%2Bversion.pdf+&cd=1&hl=de&ct=clnk&gl=it
• 14 BMA. Merkblatt zur BK Nr. 4104: Lungenkrebs oder Kehlkopfkrebs. BArbBl 1997; 12: 32
• 15 Gustavsson P. Nyberg F. Pershagen G. et al. Low-dose exposure to asbestos and lung cancer: dose-response relations and interaction with smoking in a population-based case-referent study in Stockholm, Sweden. American journal of epidemiology 2002; 155: 1016-1022
• 16 Hein MJ. Stayner LT. Lehman E. et al. Follow-up study of chrysotile textile workers: cohort mortality and exposure-response. Occup Environ Med 2007; 64: 616-625
• 17 Stayner L. Smith R. Bailer J. et al. Exposure-response analysis of risk of respiratory disease associated with occupational exposure to chrysotile asbestos. Occup Environ Med 1997; 54: 646-652
• 18 Baur X. Soskolne CL. Lemen RA. et al. How conflicted authors undermine the World Health Organization (WHO) campaign to stop all use of asbestos: spotlight on studies showing that chrysotile is carcinogenic and facilitates other non-cancer asbestos-related diseases. Int J Occup Environ Health 2015; 21: 176-179
• 19 Baur X. Orientierungshilfe in ethischen Spannungsfeldern. Landsberg: ecomed Medizin; 2009
• 20 Baur X. Asbestbedingte Erkrankungen. Kein Ende in Sicht. Dtsch Ärztebl 2016; 113: 26-28
• 21 Baur X. Woitowitz HJ. [Lung Cancer as an Occupational Disease]. Pneumologie 2016; 70: 510-513
• 22 Baur X. Budnik LT. Ruff K. et al. Ethics, morality, and conflicting interests: how questionable professional integrity in some scientists supports global corporate influence in public health. Int J Occup Environ Health 2015; 21: 172-175
• 23 Egilman D. Bird T. Lee C. Dust diseases and the legacy of corporate manipulation of science and law. Int J Occup Environ Health 2014; 20: 115-125
• 24 Egilman D. Wallace W. Hom C. Corporate corruption of medical literature: asbestos studies concealed by W.R. Grace & Co. Accountability in research 1998; 6: 127-147
• 25 Welch LS. Asbestos exposure causes mesothelioma, but not this asbestos exposure: an amicus brief to the Michigan Supreme Court. Int J Occup Environ Health 2007; 13: 318-327
• 26 Oreskes N. Conway EM. Merchants of doubt: how a handful of scientists obscured the truth on issues from tobacco smoke to global warming. New York: Bloombury Press; 2011
• 27 Michaels D. Doubt Is their product how industrys assault on science threatens your health. New York: Oxford University Press; 2016
• 28 Mandrioli D. Silbergeld EK. Evidence from toxicology: the most essential science for prevention. Environ Health Perspect 2016; 124: 6-11
• 29 Mandrioli D. Kearns CE. Bero LA. Relationship between research outcomes and risk of bias, study sponsorship, and author financial conflicts of interest in reviews of the effects of artificially sweetened beverages on weight outcomes: A Systematic Review of Reviews. PloS one 2016; 11: e0162198
• 30 Egilman DS. Bird T. Lee C. MetLife and its corporate allies: dust diseases and the manipulation of science. Int J Occup Environ Health 2013; 19: 287-303
• 31 Egilman DS. Reinert A. Corruption of previously published asbestos research. Arch Environmental Health 2000; 55: 75-76